What does the Congenital Dyserythropoietic Anemia Gene Panel include at Metropolis Healthcare?
It includes targeted NGS analysis of genes known to cause various CDA subtypes.
How does Metropolis Healthcare perform this genetic test?
Metropolis Healthcare uses high-depth Next-Generation Sequencing along with expert bioinformatic review for precise variant detection.
Who should consider taking this test at Metropolis Healthcare?
Individuals with unexplained chronic anemia, abnormal bone marrow findings, or a family history of CDA may benefit.
What type of sample is required for this CDA panel at Metropolis Healthcare?
A blood sample collected in an EDTA tube is used for sequencing.
How can this test help in clinical management?
It helps confirm the genetic subtype, guide treatment plans, and support long-term monitoring.
How long does Metropolis Healthcare take to provide results?
The typical turnaround time is 2–4 weeks depending on sequencing complexity.
Can this test identify carriers of congenital dyserythropoietic anemia?
Yes, the panel can detect carrier status, which is useful for family planning.
Is genetic counseling recommended after testing at Metropolis Healthcare?
Yes, counseling helps interpret results and understand inheritance patterns.